GenomtecWAR:GMT +1.49%26 Beneish M-Score is 22.76 as of Jun. 25, 2026, which is 119% above its 10-year median of 10.37. GuruFocus rates WAR:GMT with a GF Score™ of 26/100. The stock has 3 warning signs investors should review. Among 765 Medical Devices & Instruments companies, Genomtec ranks worse than 99.08% on this metric.
The zones of discrimination for M-Score is as such:
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Warning Sign:
Beneish M-Score 22.76 higher than -1.78, which implies that the company might have manipulated its financial results.
The historical rank and industry rank for Genomtec's Beneish M-Score or its related term are showing as below:
WAR:GMT'
s Beneish M-Score Range Over the Past 10 Years
Min: -4.76 Med: 10.37 Max: 124.46
Current: 22.76
During the past 8 years, the highest Beneish M-Score of Genomtec was 124.46. The lowest was -4.76. And the median was 10.37.
Genomtec Beneish M-Score Related Terms
Genomtec Beneish M-Score Historical Data
* Premium members only.
The historical data trend for Genomtec's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WAR:GMT vs ABT, SYK, MDT: Beneish M-Score Comparison
For the Medical Devices subindustry, Genomtec's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Genomtec Beneish M-Score vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Genomtec's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Genomtec's Beneish M-Score falls into.
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Genomtec for today is based on a combination of the following eight different indices:
M
=
-4.84
+
0.92 * DSRI
+
0.528 * GMI
+
0.404 * AQI
+
0.892 * SGI
+
0.115 * DEPI
=
-4.84
+
0.92 * 0.8116
+
0.528 * 2.9714
+
0.404 * 1.3007
+
0.892 * 5.3333
+
0.115 * 0.766
-
0.172 * SGAI
+
4.679 * TATA
-
0.327 * LVGI
-
0.172 * 0.1535
+
4.679 * 0.018807
-
0.327 * 1.3307
=
2.47
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
DEPI
=
(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))
/
(Depreciation_t / (Depreciaton_t + PPE_t))
=
(2.351 / (2.351 + 2.489))
/
(2.903 / (2.903 + 1.675))
=
0.485744
/
0.63412
=
0.766
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
TATA
=
(IncomefromContinuingOperations_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(NetIncome_t - NonOperatingIncome_t
-
CashFlowsfromOperations_t)
/
TotalAssets_t
=
(-9.422 - 0
-
-9.667)
/
13.027
=
0.018807
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Genomtec has a M-score of 2.47 signals that the company is likely to be a manipulator.
Genomtec (WAR:GMT) has a Beneish M-Score of 22.76 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Genomtec and its competitors. This is 119% above median its historical median of 10.37. According to the industry distribution chart, Genomtec ranks #758 out of 765 companies in the Medical Devices & Instruments industry, placing it in the top 99.1%.
Is Genomtec's Beneish M-Score too high?
Genomtec's current Beneish M-Score of 22.76 is 119% above median its 10-year median of 10.37. Based on the distribution chart, Genomtec ranks #758 out of 765 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Genomtec has a GF Score™ of 26/100, reflecting its overall financial health beyond just this single metric.
How does Genomtec's Beneish M-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Genomtec ranks #758 out of 765 companies for Beneish M-Score. This places Genomtec in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Medical Devices & Instruments company?
A good Beneish M-Score depends on the Medical Devices & Instruments industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Genomtec and its competitors. Genomtec's current Beneish M-Score is 22.76, which is 119% above median its own 10-year median of 10.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genomtec stock overvalued right now?
Genomtec (WAR:GMT) has a current Beneish M-Score of 22.76. The current Beneish M-Score is 22.76, which is 119% above median its 10-year median of 10.37. Genomtec's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Genomtec (WAR:GMT), the current Beneish M-Score is 22.76 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Genomtec SA is an technology company which works in the area of ?? molecular diagnostics. It is a manufacturer of mobile molecular analyzers. The device are designed to identify pathogens including viruses, bacteria, and fungi by amplifying and detecting specific DNA and RNA fragments.
26GF Score
Get the complete analysis for WAR:GMT
Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WAR:GMT has been successfully added to your 
